Ming Li

PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China.

Growatt Technology Co., Ltd. is a holding company, which engages in the design, development, and distribution of energy solutions. It operates through the following segments: Photovoltaics (PV) Inverters, Energy Storage Products, and Smart Energy Management System and Others. The PV Inverters segment includes design and manufacture of PV inverters for homeowners, commercial and industrial (C&I) businesses, and utility projects. The Energy Storage Products segment offers battery-ready inverters, on-grid storage inverters, micro-grid inverters, and battery packs. The Smart Energy Management System and Others segment refers to smart electric vehicles (EV) chargers, monitoring devices, and smart energy management apps. The company was founded by Yong Qiang Ding in March 2011 and is headquartered in Shenzhen, China.

Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors.

Part of WuXi AppTec Co., Ltd., WuXi AppTec (Shanghai) Co. Ltd. develops and manufactures pharmaceuticals. The company is based in Shanghai, China.

Part of Johnson & Johnson, Johnson & Johnson (China) Investment Ltd. is a Chinese company that provides investment services. The company is based in Shanghai, China.

Part of Pfizer Inc., Pfizer Investment Co. Ltd. is a Chinese company that provides investment and investments consulting services. The company is based in Shanghai, China.

The Association of Chartered Certified Accountants (ACCA) is a professional body for accountants. The non-profit company is based in Glasgow, UK, and has subsidiaries in Mauritius, United Kingdom, and Hong Kong. The British company offers a program called ALP-C, which approves learning materials from high-quality content providers to support studying towards ACCA's qualification. The role of the CFO is evolving beyond finance to include reporting on value-centric aspects of their operations, as companies move towards sustainable practices. The CEO of the company is Helen Joanna Brand.

KPMG Hong Kong provides accounting services. The private company is based in Hong Kong, Hong Kong and has subsidiaries in Hong Kong.

KPMG Beijing provides taxation and tax consulting services. The private company is based in Beijing, China.

Jiangsu Convac Biotechnology Co., Ltd. engages in the research and development, production, and sale of biological products. It offers new vaccines, genetic modified drugs and in vitro diagnostic reagents. The company was founded on October 13, 2011 and is headquartered in Taizhou, China.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

New World China Land Ltd. is an investment holding company, which engages in the investment and development of real estate properties. The company was founded on May 17, 1999 and is headquartered in Guangzhou, China.

TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA.

Innovex Medical Co., Ltd. provides surgical solutions. It is a provider of integrated non-vascular interventional surgical solutions in China with a global vision. It offer integrated solutions of endoscopes, active medical devices and non-active consumables for all major medical specialties that perform non-vascular interventional surgery, including urology, gastroenterology, hepatobiliary, respiratory, thoracic surgery, otorhinolaryngology, gynecology and general surgery. The company was founded in February 02, 2009 and is headquartered in Shanghai, China.

Yonjin Venture LLC (Yonjin Venture) is a venture capital subsidiary of Yongjin Group, Inc. founded in 2018. The firm is headquartered in Cambridge, Massachusetts.

ITabMed Co., Ltd. is a Chinese clinical-stage biotech company that focuses on the discovery and development of immunotherapy products to treat cancer. The company is based in Shanghai, China. ITabMed Co. was founded in 2020 by Xiaoqiang Yan, who has been the CEO since 2020.

Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.

6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017.

Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China.

Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China.